版本:
中国

BRIEF-Vaccinex announces clinical collaboration with Merck Kgaa

Oct 6 Vaccinex Inc:

* Vaccinex announces clinical collaboration with Merck Kgaa, Darmstadt, Germany, to evaluate the combination of VX15/2503, and avelumab in non-small cell lung cancer

* Vaccinex will be responsible for conducting planned phase IB/II clinical trial

* Further details of collaboration were not disclosed Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐